Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
7.82
-0.30 (-3.69%)
May 13, 2025, 4:00 PM - Market closed

Aurinia Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
66.1183.448.7694.09231.64272.35
Upgrade
Short-Term Investments
246.47275.04301.61295.22234.18125.98
Upgrade
Cash & Short-Term Investments
312.59358.44350.37389.31465.82398.33
Upgrade
Cash Growth
-2.12%2.30%-10.00%-16.43%16.94%30.16%
Upgrade
Accounts Receivable
40.3536.5424.0913.4815.41-
Upgrade
Other Receivables
0.20.60.71.1--
Upgrade
Receivables
40.5537.1424.7914.5815.41-
Upgrade
Inventory
46.239.2339.7124.7519.3313.93
Upgrade
Prepaid Expenses
5.5411.229.4913.5811.715.76
Upgrade
Restricted Cash
0.320.040.120.080.26-
Upgrade
Other Current Assets
0.580.530.330.230.81.42
Upgrade
Total Current Assets
405.76446.6424.8442.54513.32419.43
Upgrade
Property, Plant & Equipment
94.1198.87116.578.569.810.28
Upgrade
Long-Term Investments
--0.2--24.38
Upgrade
Other Intangible Assets
4.164.364.986.438.49.33
Upgrade
Other Long-Term Assets
0.820.821.5213.3411.840.25
Upgrade
Total Assets
504.85550.65548.06470.86543.37463.66
Upgrade
Accounts Payable
4.225.194.333.093.882.64
Upgrade
Accrued Expenses
41.7354.1250.0636.2830.2522.16
Upgrade
Current Portion of Leases
15.5415.0715.60.941.060.79
Upgrade
Current Income Taxes Payable
---0.630.81-
Upgrade
Current Unearned Revenue
4.59114.813.150.19-
Upgrade
Other Current Liabilities
2.3212.392.392.034.456.41
Upgrade
Total Current Liabilities
68.4197.7677.1946.1140.6532
Upgrade
Long-Term Leases
62.3764.382.017.157.687.62
Upgrade
Long-Term Unearned Revenue
12.45-----
Upgrade
Other Long-Term Liabilities
11.4411.1110.9112.1715.9516.3
Upgrade
Total Liabilities
154.66173.17170.1165.4364.2855.91
Upgrade
Common Stock
1,1631,1881,2001,1851,177944.33
Upgrade
Additional Paid-In Capital
100.98127120.7985.4959.0139.38
Upgrade
Retained Earnings
-913.23-936.57-942.32-864.3-756.12-575.16
Upgrade
Comprehensive Income & Other
-0.83-0.65-0.73-1.06-0.85-0.81
Upgrade
Shareholders' Equity
350.19377.48377.95405.44479.09407.75
Upgrade
Total Liabilities & Equity
504.85550.65548.06470.86543.37463.66
Upgrade
Total Debt
77.9179.3797.618.098.748.41
Upgrade
Net Cash (Debt)
234.68279.07252.76381.22457.08389.92
Upgrade
Net Cash Growth
1.67%10.41%-33.70%-16.60%17.22%27.42%
Upgrade
Net Cash Per Share
1.611.911.762.693.533.29
Upgrade
Filing Date Shares Outstanding
135.1137.34144.62142.58141.65127.45
Upgrade
Total Common Shares Outstanding
137.75140.88143.83142.27141.6126.73
Upgrade
Working Capital
337.36348.83347.61396.43472.68387.43
Upgrade
Book Value Per Share
2.542.682.632.853.383.22
Upgrade
Tangible Book Value
346.03373.12372.98399.01470.69398.42
Upgrade
Tangible Book Value Per Share
2.512.652.592.803.323.14
Upgrade
Machinery
2.022.022.021.871.880.46
Upgrade
Construction In Progress
---0.260.394.47
Upgrade
Leasehold Improvements
3.243.243.242.982.980.03
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q